Evidence for the role of proteinases in uremic catabolism.
Enhanced muscle protein breakdown has been demonstrated in acutely uremic rats by numerous authors. In order to investigate the pathogenetic role of skeletal muscle proteinases leupeptin, a low-molecular weight proteinase inhibitor, was administered intraperitoneally to acutely uremic rats. Twenty-four hours after bilateral nephrectomy, leupeptin-treated animals displayed significantly lowered serum urea levels (-32%), as compared to untreated uremic rats. As a sign of muscle protein breakdown, plasma levels of Nt-methylhistidine, an indicator of myofibrillar protein degradation, were also decreased (-35%) in the uremic animals treated with leupeptin as compared to untreated uremic rats. Finally, leupeptin treatment resulted in a significant inhibition of the myofibrillar alkaline proteinase activity, a proteinase which has been related to various catabolic conditions. These findings suggest that the increased muscle protein breakdown in uremia is caused by enhanced activity of muscular proteinases and that anti-proteolytic agents display favourable effects on the enhanced protein degradation observed in acute uremia.
Schaefer
R M
RM
Department of Medicine, University of Wuerzburg, FRG.
Teschner
M
M
Peter
G
G
Leibold
J
J
Kulzer
P
P
Heidland
A
A
D000208:Acute Disease; D000818:Animals; D001774:Blood Chemical Analysis; D010450:Endopeptidases / Q000378:metabolism / Q000502:physiology*; D006868:Hydrolysis; D007976:Leupeptins / Q000494:pharmacology; D008297:Male; D008762:Methylhistidines / Q000097:blood / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism; D009392:Nephrectomy; D011480:Protease Inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D014511:Uremia / Q000201:enzymology / Q000378:metabolism*
D007976:Leupeptins; D008762:Methylhistidines; D009124:Muscle Proteins; D011480:Protease Inhibitors; D010450:Endopeptidases; C032854:leupeptin